|
|
7th Principal Investigators Meeting Agenda
7th Principal Investigators Meeting
Innovative Molecular Analysis Technologies Program
September 7-8, 2006
Bethesda Marriot Hotel (Pooks Hill)
Bethesda, Maryland
Agenda
THURSDAY, SEPTEMBER 7, 2006 |
7:30 a.m. - 8:30 a.m. |
Registration and Continental Breakfast |
7:30 a.m. - 8:30 a.m. |
Poster Setup |
8:30 a.m. - 8:50 a.m. |
Welcoming Remarks
Gregory J. Downing, D.O., Ph.D.
National Cancer Institute
|
8:50 a.m. - 9:50 a.m. |
Keynote Presentation
Systems Approaches to Predictive Marker Development
Joe W. Gray, Ph.D.
Lawrence Berkeley National Laboratory
|
9:50 a.m. - 10:00 a.m. |
Break |
10:00 a.m. - 12:20 p.m. |
Session 1: Sample Preparation
Moderator: Rebecca L. Huppi, Ph.D.
National Cancer Institute
Determining Agreement in Molecular Data Across Different
Methods of Tissue Procurement
Philip S. Bernard, M.D.
Huntsman Cancer Institute
Recovery of Protein From Formalin-Fixed Paraffin-
Embedded Tissue
Timothy O'Leary, M.D., Ph.D.
Veterans Health Administration
A Chip-Based RNA Sensor Platform for Detection of
Circulating Tumor Cells
Gary A. Clawson, M.D., Ph.D.
Pennsylvania State University
Microfluidic Platform for Live Cell Screening
Philip Lee, Ph.D.
CellASIC Corporation
|
12:20 p.m. - 1:20 p.m. |
Lunch |
1:20 p.m. - 2:05 p.m. |
Electronic Submissions and Alternative Funding Opportunities
SF424/Electronic Transition Requirements
Scarlett Gibb
National Institutes of Health
Alternative Funding Opportunities
Jennifer Couch, Ph.D.
National Cancer Institute
|
2:05 p.m. - 2:15 p.m. |
Break |
2:15 p.m. - 4:15 p.m. |
Session 2: Proteomics
Moderator: Paul Wagner, Ph.D.
National Cancer Institute
Mapping Endothelium and Its Caveolae In Vivo to Improve Antibody Pentetration, Imaging, and Therapy of Solid Tumors
Jan E. Schnitzer, M.D.
Sidney Kimmel Cancer Center
Diverse Novel Approaches for Proteomics of Posttranslational Modifications
Yingming Zhao, Ph.D.
University of Texas Southwestern Medical Center
Selective Profiling of Proteins in Cancer Cells From
Fine-Needle Aspirates by MALDI-TOF Mass Spectrometry
Michelle L. Reyzer, Ph.D.
Vanderbilt University
Detection and Identification of Cysteine Sulfenic Acids in
Proteins Involved in Signal Transduction Pathways
Leslie B. Poole, Ph.D.
Wake Forest University School of Medicine
Nanoparticles for Efficient Delivery to Solid Tumors
Suzie Pun, Ph.D.
University of Washington
|
4:15 p.m. - 5:45 p.m. |
Poster Session
|
FRIDAY, SEPTEMBER 8, 2006 |
8:00 a.m. - 9:00 a.m. |
Registration and Continental Breakfast |
9:00 a.m. - 11:30 a.m. |
Session 3: Cellular Imaging
Moderator: Jennifer Couch, Ph.D.
National Cancer Institute
Identifying the Cancer Stem Cell: Lessons Learned From Hematopoiesis and Acute Leukemia
Scott W. Hiebert, Ph.D.
Vanderbilt University
Automated Cell Preparation in Tubes for 3D Microscopy
Mark R. Holl, Ph.D.
University of Washington
Imaging Transcriptional Activation in Gliomas
E. Antonio Chiocca, M.D., Ph.D.
James Cancer Hospital and Solove Research Institute
Sensing and Imaging Activated Fibroblast in Tumor Stroma
Ching Tung, Ph.D.
Massachusetts General Hospital/Harvard Medical School
Age-Dependent Accumulation of Recombinant Cells
in the Mouse Pancreas Revealed In Situ by Fluorescence
Imaging
Bevin Engleward, Ph.D.
Massachusetts Institute of Technology
|
11:30 a.m. - 12:30 p.m. |
Lunch |
12:30 p.m. - 2:30 p.m. |
Session 4: Molecular Biology
Moderator: J. Randy Knowlton, Ph.D.
National Cancer Institute
Development of High-Throughput Methods for the in vitro Selection of RNA Aptamers That Can Distinguish Between Tumor Cell Types
Andrew D. Ellington, Ph.D.
University of Texas at Austin
Facile Characterization of Protein Structure/Function With Enhanced Peptide Amide Hydrogen/Deuterium Exchange Mass Spectrometry (DXMS)
Virgil L. Woods, Jr., M.D.
University of California, San Diego
Analysis of Genetic and Epigenetic Alterations in DNA Archives Generated From Tumors of the Head and Neck
Paul M. Lizardi, Ph.D.
Yale University School of Medicine
Prostate Cancer Gene Discovery Using Transposon-Based Somatic Mutagenesis
Lara S. Collier, Ph.D.
University of Minnesota Cancer Center
Solid-Phase Assays of Oncogenic Tyrosine Kinase Activity
for Use in Diagnostics and Drug Discovery
Stephen J. Kron, M.D., Ph.D.
University of Chicago
|
2:30 p.m. - 3:00 p.m. |
Closing Remarks |
3:00 p.m. |
Adjournment and Poster Removal |
|